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Abstract
The diagnostic value of serum procalcitonin (PCT) to dis-
tinguish blood contamination from bloodstream infection
(BSI) due to coagulase-negative staphylococci was evaluated.
Patients with BSI had higher PCT concentration than those
with blood contamination at day –1, day 0 and day +1 with
regard to blood culture collection (p < 0.05), whereas serum C-
reactive protein values were significantly higher only on day
+1. At a cutoff of 0.1 ng/dl, PCT had a sensitivity of 86% and
100%, and a specificity of 60% and 80% for the diagnosis of
BSI on day –1 and 0, respectively. In addition to clinical and
microbiological parameters, PCT may help discriminating blood
contamination from BSI due coagulase-negative staphylococci.
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Introduction
Coagulase-negative staphylococci as ubiquitous skin
commensals are both, the most common cause of noso-
comial bloodstream infection (BSI) and blood culture
contamination [1–3]. It is important to distinguish blood
contamination from BSI to promptly initiate an adequate
therapy in BSI and, in contamination to avoid unnecessary
antimicrobial usage and healthcare expenditures, reduce
the selection pressure on microorganisms and prevent
potential drug adverse events.
Early and accurate parameters to distinguish con-
taminated blood from BSI are lacking [4]. Serum pro-
calcitonin (PCT) has emerged as a biomarker for
diagnosis of various bacterial infections and was found to
have higher diagnostic accuracy as compared to clinical
characteristics or commonly used laboratory parameters,
such as white blood count (WBC) and serum C-reactive
protein (CRP) [5–9]. However, the diagnostic accuracy of
PCT to distinguish blood culture contamination from BSI
is not known. Therefore, we prospectively compared PCT
values with currently used routine clinical, microbiological
and laboratory parameters to predict BSI due to coagu-
lase-negative staphylococci.
Patients and Methods
The study was conducted at the University Hospital Basel in
Switzerland, a 950-bed tertiary healthcare center. We prospec-
tively included consecutive patients ‡ 18 years of age admitted
to our hospital between 1 April and 31 August 2005, from whom
at least one blood culture grew coagulase-negative staphylococci.
Patients with one or more positive blood cultures collected
within 10 days were considered as one episode. Patients with
positive blood cultures from outside hospitals and those obtained
postmortem were excluded from the analysis. Blood cultures
were processed using an automated colorimetric detection sys-
tem (BacT/ALERT, bioMerieux, Durham, NC, USA) [10]. The
time to positivity was defined as the time between the start of
incubation and the instrument signal indicating growth in either
the aerobic or anaerobic blood culture bottle, confirmed by
Gram staining.
Patient records were reviewed with a standardized data-
collection case report form to retrieve demographic, clinical,
microbiological, radiographic, and laboratory data, including
systemic inflammatory response syndrome (SIRS) criteria, and
the number of positive and the total number of collected blood
cultures. Patients were classified by the attending physician and
his or her supervisor on the ward using clinical judgment, routine
laboratory results and Centers for Disease Control and Preven-
tion (CDC) criteria for nosocomial infections [11]. BSI was
diagnosed if at least two SIRS criteria were present and at least
one of the following criteria was fulfilled: (i) ‡ 2 positive blood
cultures with coagulase-negative staphylococci or (ii) time to
positivity was < 15 h after blood culture collection. An infectious
disease specialist, who was not aware about the PCT values,
prospectively classified episodes into (i) blood contamination
due to coagulase-negative staphylococci, (ii) BSI due to coagu-
lase-negative staphylococci (without other focus of infection)
and (iii) other infection with concomitant isolation of coagulase-
negative staphylococci in blood culture. The classification of the
episodes was confirmed by an independent senior infectious
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diseases consultant. Blood culture collection, microbiological
tests and antibiotic therapy were prescribed by attending physi-
cians per usual practice. The Institutional Review Board classi-
fied the study as a quality control study and waived the need for
patient informed consent.
Laboratory analyses included the determination of WBC
and CRP from the routinely collected blood analysis of all pa-
tients. CRP concentrations were determined by an enzyme
immunoassay having a detection limit of < 5 mg/dl (EMIT,
Merck Diagnostica, Zurich, Switzerland). To insure true blinding
in regard to PCT values, blood samples were collected from
laboratory stock at day –1, day 0 and day +1 with regard to
blood culture collection and stored at –70 C. At the end of the
study, PCT was determined as a batch analysis using an ultra-
sensitive immuno-luminometric assay having a functional
detection limit of < 0.05 ng/ml (PCT sensitive LIA, Brahms,
Berlin, Germany).
To evaluate differences between groups, the unpaired Stu-
dent’s t-test for normally distributed continuous variables and
the Mann–Whitney U-test or Fisher’s exact test for categorical
variables was used, as appropriate. If CRP or PCT was not
detectable, a value equal to the limit of detection for the assay
was assigned. To compare the diagnostic value of individual
laboratory markers for diagnosing BSI, we performed a receiver
operating characteristic (ROC) analysis [12]. The area under the
ROC curve (AUC) was the measure of the accuracy of labora-
tory parameters to distinguish both groups. A p-value < 0.05 (for
a 2-sided test) was considered statistically significant. All calcu-
lations were performed using statistical software MedCalc for
Windows (version 7.2.1.0, Mariakerke, Belgium).
Results
A total of 40 patients (median age 63 years; range 18–
89 years, 65% men) were included; 12 were classified as
blood contamination, 7 as BSI due to coagulase-negative
staphylococci and 21 as having an infection other than due
to coagulase-negative staphylococci. The underlying
medical conditions included hematological and solid
malignancies (48%), cardiovascular disease (28%), respi-
ratory disease (13%), gastrointestinal disease (10%), re-
nal failure (10%) and drug abuse (15%). The most
probable reasons for fever in 12 patients with blood con-
tamination were malignancy (n = 3), viral infection
(n = 2), rheumatologic inflammatory disease (n = 1), or
the reason was unknown (n = 6). All seven patients with
BSI due to coagulase-negative staphylococci had vascular
catheters inserted at the time of blood culture collection
(five with central venous catheters, two with peripheral
venous catheters). In three patients with BSI the catheter
was removed and in two of them > 15 colonies of coagu-
lase-negative staphylococci grew on the removed catheter
tip culture using the roll-plate method. In patients with
underlying infection, pneumonia (n = 12), urosepsis
(n = 4), soft tissue infection (n = 3), endocarditis (n = 1),
fever in neutropenia without pathogen identification
(n = 1) were diagnosed. In this group, the following
causative microorganisms were isolated: Streptococcus
pneumoniae (n = 4), Streptococcus pyogenes (n = 1),
Escherichia coli (n = 3), Enterobacter cloacae (n = 1) and
no pathogen found (n = 11). Empiric antimicrobial ther-
apy received all 7 patients with BSI due to coagulase-
negative staphylococci, 15 of 21 patients (71%) with an
underlying infection other than due to coagulase-negative
staphylococci and 2 of 12 patients (17%) with blood
contamination.
At the time of blood culture collection, mean body
temperature (± standard deviation) was 38.6 C (± 1.0) in
patients with BSI due to coagulase-negative staphylo-
cocci, 38.7 C (± 0.6) in patients with underlying infec-
tion and 37.9 C (± 0.8) in patients with blood
contamination. All patients with underlying infection had
> 2 SIRS criteria present, namely fever (n = 6), tachy-
cardia (n = 4), tachypnea (n = 3), leukocytosis or leuco-
penia (n = 4). In patients with blood contamination one
SIRS criterion was present in six patients [fever (n = 3),
tachycardia (n = 2), leukocytosis or leucopenia (n = 1)];
two SIRS criteria were present in three patients [fever
(n = 3), tachycardia (n = 1), leukocytosis or leucopenia
(n = 2)].
Table 1 shows laboratory markers of the patients with
blood contamination and BSI due to coagulase-negative
staphylococci. Patients with BSI had significantly higher
PCT at all time points (day –1, day 0 and day +1) than
those with blood contamination, whereas CRP values
were significantly higher only on day +1 (Figure 1). The
time to positivity was < 15 h for 6 of 7 patients deter-
mined to have BSI and for only 1 of 12 patients with blood
contamination The proportion of positive blood culture
bottles in patients with BSI was 67% (3.0 of 4.5 bottles) as
compared to 34% (1.3 of 3.8 bottles) in those patients with
blood contamination. In patients with underlying infec-
tion, laboratory parameters were influenced by the
underlying infection and were therefore excluded in fur-
ther comparisons.
As determined by the ROC curve analysis, PCT was
an accurate blood marker for distinguishing BSI from
blood contamination (Table 1). At any time points,
namely at day –1, day 0 and day +1, the accuracy of PCT
was significantly higher than the one of CRP (p < 0.01).
For PCT, the cutoff of 0.1 ng/dl had a sensitivity, speci-
ficity, positive and negative likelihood ratio of 86%, 60%,
2.2 and 0.2 (at day –1), 100%, 80%, 6.0 and 0.1 (at day 0)
and 100%, 84%, 4.2 and 0.2 (at day +1), respectively.
Discussion
Previous studies have focused on finding a sensitive
diagnostic marker for prediction of BSI and early guid-
ance of antimicrobial therapy, however, accurate diag-
nostic criteria are still lacking [4]. Microbiological
characteristics like capability of biofilm production,
quantitative blood cultures, the proportion of positive
blood cultures or the time to positivity of blood cultures
has been suggested to be discriminative in this setting [4,
9, 13]. In Staphylococcus aureus, the time to positivity of
blood cultures provided useful diagnostic and prognostic
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information; growth within 12–14 h after the initiation of
incubation identified patients with a high likelihood of
endovascular infection sources, delayed bacterial clear-
ance and septic complications [14]. However, the time
delay of several days and the financial cost are major
disadvantages of this approach.
Commonly used blood markers such as WBC and
CRP may be elevated, but often reflect the nonspecific
systemic inflammatory response to the underlying disease
state rather than to BSI. In this study, PCT at a low cutoff
of 0.1 ng/ml was an early and accurate laboratory
parameter to distinguish BSI from blood contamination
due to coagulase-negative staphylococci, which was
superior to the accuracy of CRP. These findings are
consistent with other reports in comparable settings,
showing that PCT is a more reliable parameter for dis-
tinguishing infectious from non-infectious febrile episodes
and for initiation and guidance of antimicrobial treatment
[5–8, 15]. Our findings also underline the importance of
the use of more sensitive PCT assays to appreciate its full
diagnostic potential [16].
An important finding of our study was the increased
values of PCT 1 day prior to clinical manifestation of BSI
and collection of blood cultures. The early increase of
PCT may reflect the colonization of the catheter with
subclinical infection ultimately leading to BSI [17]. CRP
was discriminative only at 1 day after blood culture col-
lection; even at this point, PCT had a superior diagnostic
accuracy. Since contamination due to coagulase-negative
staphylococci is occurring in approximately 23% of all
collected blood cultures [1, 4, 18], correct evaluation of
their significance is important.
Limitations of this exploratory study are the small
sample size and the heterogeneity of patients regarding
their underlying diseases and the cause of febrile epi-
sodes. In patients with polymicrobial BSI, PCT may be
of limited value to diagnose BSI caused by coagulase-
negative staphylococci, since the additional microorgan-
ism(s) may be responsible for the increased PCT
concentration. PCT values need to be evaluated with
caution in neutropenic patients since the course of the
bacterial infection can be overwhelmingly fast in neu-
tropenia devoid of an efficient host defense [6]. Fur-
thermore, the specificity of PCT may be limited in
patients with lung and thyroid cancer [19]. Therefore,
our results need to be confirmed in larger studies. An-
other limitation relates to the observed time to positivity
which may be affected by different time from the blood
collection until incubation, since bacterial growth at
room temperature (22 C) is considerably slower than at
incubator temperature (37 C).
In conclusion, if confirmed in larger studies, PCT
may serve as an early and more accurate surrogate
marker for differentiation of BSI from blood contami-
nation due to coagulase-negative staphylococci, espe-
cially when used as an adjunct to clinical, other
laboratory and microbiological parameters. Early iden-
tification of patients with blood contamination has great
clinical relevance for an improved diagnostic approach
and to prevent unnecessary antimicrobial treatment.
However, determination of PCT should never substitute
a careful history, physical examination and evaluation of
other laboratory parameters, including time to positivity
of blood cultures.
Table 1
White blood count, C-reactive protein, procalcitonin, time to positivity of blood cultures and proportion of positive blood culture bottles
in patients with blood contamination and bloodstream infection due to coagulase-negative staphylococci.
Laboratory marker Time regarding to
blood collection
Blood contamination
(n = 12)
Bloodstream
infection
(n = 7)
AUC (95% confidence
interval)a
WBC (· 109/l)b Day –1 9.3 (0.1–11.9) 11.1 (1.1–25.0) –
Day 0 8.6 (0.1–12.0) 11.5 (0.5–28.0) –
Day +1 6.3 (0.1–12.0) 16.0 (0.5–31.0) –
CRP (mg/dl) Day –1 48 (4–207) 48 (16–278) 0.56 (0.38–0.80)
Day 0 30 (4–193) 64 (47–417) 0.67 (0.42–0.87)
Day +1 45 (4–147) 168 (36–212) 0.80 (0.54–0.96)
PCT (ng/ml) Day –1 0.09 (0.05–0.18) 0.50 (0.06–5.27) 0.87 (0.62–0.98)
Day 0 0.08 (0.05–0.23) 0.62 (0.14–5.20) 0.98 (0.78–0.98)
Day +1 0.08 (0.05–0.20) 0.55 (0.15–2.70) 0.97 (0.74–0.98)
Time to positivity of blood cultures (h)b 19.1 (6.7–27.5) 10.7 (3.9–29.7) –
No. positive blood culture bottles/no. totalb 1.3 (1–2)/3.8 (2–8) 3.0 (1–6)/4.5 (2–6) –
WBC: white blood cell count; CRP: C-reactive protein; PCT: procalcitonin; AUC: area under the curve. Data represent median values (range).
Where AUC data are missing, no statistical comparison was performed since the parameter was considered a diagnostic criterion for blood-
stream infection; a The area under the ROC curve (AUC) was used to assess the accuracy of laboratory parameters to distinguish blood
contamination from bloodstream infection; b Considered a diagnostic criterion for bloodstream infection.
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Figure 1. CRP (a) and PCT (b) values in patients with blood con-
tamination (left side, fine lines) and bloodstream infection (right
side, strong lines) the day before (day –1), the day of (day 0) and the
day after (day +1) blood culture collection. Horizontal lines in boxes
denote median values, boxes represent 25 and 75 percentiles and
whiskers indicate the range. Values are missing for two subjects on
day –1 and for three subjects on day +1.
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